AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, for treating moderate-to-severe atopic dermatitis (AD), also known as ...

The Select Board recently denied two tax abatement requests from local landowners, advising them to seek relief through the ...

The study focused on two proteins that appear on the surface of immune cells, B and T lymphocyte attenuator (BTLA) and herpesvirus entry mediator (HVEM). BTLA and HVEM form a protein complex as ...

Hosted this Sunday at Museum of Human Achievement, BTLA and HoT’s Trans Day of Visibility celebration features drag, conversation, and magic – all of which originates within the local trans ...